The Bayh-Dole Act: Selected Issues in Patent Policy and the Commercialization of Technology
暂无分享,去创建一个
[1] Edwin Mansfield,et al. Social Returns from R&D: Findings, Methods and Limitations , 1991 .
[2] Wesley M. Cohen,et al. Working Through the Patent Problem , 2003, Science.
[3] E. Emanuel,et al. Technology licensing: lessons from the US experience. , 2005, JAMA.
[4] E. Plibus. Congressional Record , 2006 .
[5] B. Sampat. Patenting and US academic research in the 20th century: The world before and after Bayh-Dole , 2006 .
[6] Mark A. Bloomfield,et al. Intellectual property rights and capital formation in the next decade , 1988 .
[7] Wendy H. Schacht. Cooperative R&D: Federal Efforts to Promote Industrial Competitiveness , 2006 .
[8] Ann Thayer. University Technology Moves to Market via Patenting, Licensing: Licensing deals with industry have climbed and have led to new products, but schools aren't getting rich , 1992 .
[9] Wendy H. Schacht. Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship , 2011 .
[10] E. Mansfield. Academic research and industrial innovation: An update of empirical findings1 , 1998 .
[11] A. Bennett,et al. Bayh-Dole: if we knew then what we know now , 2006, Nature Biotechnology.
[12] Marie C. Thursby,et al. Has the Bayh-Dole act compromised basic research? , 2011 .
[13] R. Rowberg. Pharmaceutical Research and Development: A Description and Analysis of the Process , 2001 .
[14] Rebecca S Eisenberg,et al. Public vs. Proprietary Science: A Fruitful Tension? , 2002, Academic medicine : journal of the Association of American Medical Colleges.
[15] Waverly W. Ding,et al. The Impact of Academic Patenting on the Rate, Quality and Direction of (Public) Research Output , 2009 .
[16] J. Bond,et al. The economic impact of licensed commercialized inventions originating in university research , 2013 .
[17] Richard Florida,et al. The Role of the University: Leveraging Talent, not Technology. , 1999 .
[18] UMMARY D ESCRIPTIONS OF THE P RIMARY V ARIABLES ’ S OURCES,et al. THE INFLUENCE OF R & D EXPENDITURES ON NEW FIRM FORMATION AND ECONOMIC GROWTH , 2002 .
[19] A M Russell,et al. Science and technology. , 1972, Science.
[20] E. Ackiron. Patents for Critical Pharmaceuticals: The AZT Case , 1991, American Journal of Law & Medicine.
[21] R. Eisenberg,et al. Bayh-Dole Reform and the Progress of Biomedicine , 2002, American Scientist.
[22] Scott Shane,et al. Encouraging university entrepreneurship? The effect of the Bayh-Dole Act on university patenting in the United States , 2004 .
[23] Marie C. Thursby,et al. Shirking, Shelving and Sharing Risk: The Role of University License Contracts , 2004 .
[24] Timothy Caulfield,et al. Evidence and anecdotes: an analysis of human gene patenting controversies , 2006, Nature Biotechnology.
[25] Arvids A. Ziedonis,et al. The growth of patenting and licensing by U.S. universities: an assessment of the effects of the Bayh–Dole act of 1980 , 2001 .
[26] David C. Mowery,et al. The Bayh-Dole Act and High-Technology Entrepreneurship in U.S. Universities: Chicken, Egg, or Something Else? , 2005 .
[27] B. Hanlon. DEPARTMENT OF COMMERCE , 2004 .
[28] Melissa S. Anderson,et al. Withholding research results in academic life science. Evidence from a national survey of faculty. , 1997, JAMA.
[29] C. Gross,et al. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. , 2003, JAMA.
[30] Marie C. Thursby,et al. University Licensing and the Bayh-Dole Act , 2003, Science.